IP Library Granted Patent US 10,864,163
Granted Patent B2
US 10,864,163 · App. 15/107,802 · Granted Dec 15, 2020

Therapeutic agents and delivery with microspheres

Inventor: Richard Michael Day (London, GB)
Assignee: UCL Business LTD
A61K9/1647A61K9/1676A61K9/1682A61K31/704A61K35/12A61K35/15A61K35/17A61K35/28A61K35/30A61K35/34A61K35/39A61K35/44A61L27/18A61L27/54A61L31/022A61L31/10A61L31/16B01J13/06A61L2300/64A61L2420/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,864,163
App. No.
15/107,802
Granted
Dec 15, 2020
Kind
B2
Abstract

The invention relates to methods for attaching therapeutic agents to structures produced by thermally induced phase separation as well as methods for coating devices and producing multi-layered microspheres.

Claims (15)

1. A method for attaching a therapeutic agent to a hydrophobic microsphere structure produced by thermally induced phase separation comprising:

i) at least partly submerging the hydrophobic microsphere structure in a culture medium;

ii) subsequently contacting the hydrophobic microsphere structure with a wetting agent that wets the hydrophobic microsphere structure, wherein the wetting agent is ethanol which is added to the culture medium to a concentration of from 10% to 30%; and

iii) attaching the therapeutic agent to the hydrophobic microsphere structure.

2. The method of claim 1 which results in the hydrophobic microsphere structure being fully submerged in the culture medium.

3. The method of claim 1 wherein the hydrophobic microsphere structure comprises poly(lactide-co-glycolide) (PLGA).

4. The method of claim 1 wherein the culture medium is Dulbecco's Modified Eagle's Medium (DMEM).

5. The method of claim 1 wherein the culture medium is tissue culture medium comprising serum.

6. The method of claim 1 wherein the hydrophobic microsphere structure is mixed with the culture medium before and after the contacting with the wetting agent.

7. The method of claim 1 further comprising incubating the hydrophobic microsphere structure at about 30° C. to about 40° C.

8. The method of claim 1 wherein the therapeutic agent is a cell.

9. The method of claim 1 wherein the therapeutic agent is an active pharmaceutical ingredient (API).

10. The method of claim 1 further comprising periods of static incubation interspersed with agitation.

11. The method of claim 10 comprising about 1 minute of agitation at about 300 rpm per hour of static incubation.

12. The method of claim 5 wherein the serum is fetal bovine serum (FBS) or fetal calf serum (FCS).

Assignments (2)
CHANGE OF NAME Recorded Nov 3, 2020
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD.
Reel/Frame 054282/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2017
From: DAY, RICHARD MICHAEL
To: UCL BUSINESS PLC
Reel/Frame 043764/0336 →
Priority Claims (1)
GB 1322869.7 · Dec 23, 2013 · national
Continuity (1)
Related Publication 20160296472A1 · Oct 13, 2016